Detalhe da pesquisa
1.
Pertuzumab as second or laterline therapy for human epidermal growth factor receptor 2positive metastatic breast cancer: A clinical experience.
Mol Clin Oncol
; 19(1): 52, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37303973